Atara Biotherapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Atara Biotherapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2012 to Q3 2024.
  • Atara Biotherapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$21.9M, a 68.6% increase year-over-year.
  • Atara Biotherapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$133M, a 54.1% increase year-over-year.
  • Atara Biotherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$276M, a 20.9% decline from 2022.
  • Atara Biotherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$228M, a 32.9% increase from 2021.
  • Atara Biotherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$340M, a 10.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$133M -$21.9M +$47.9M +68.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$181M -$19M +$52.1M +73.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-12
Q1 2024 -$233M -$31.8M +$43M +57.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-12
Q4 2023 -$276M -$60.5M +$14.1M +18.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$290M -$69.8M +$14.3M +17% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$305M -$71.1M -$89.6M -485% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-12
Q1 2023 -$215M -$74.8M +$13.3M +15.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-12
Q4 2022 -$228M -$74.6M +$18.8M +20.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$247M -$84.1M +$573K +0.68% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 -$248M $18.5M +$102M Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-01
Q1 2022 -$350M -$88.1M -$9.77M -12.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-01
Q4 2021 -$340M -$93.3M -$12M -14.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-08
Q3 2021 -$328M -$84.7M -$10.3M -13.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$318M -$83.8M -$6.34M -8.18% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$311M -$78.3M -$4.83M -6.57% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$307M -$81.3M -$2.81M -3.58% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-08
Q3 2020 -$304M -$74.3M -$2.45M -3.41% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$301M -$77.5M -$3.13M -4.21% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-04
Q1 2020 -$298M -$73.5M -$7.25M -10.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-04
Q4 2019 -$291M -$78.5M +$1.52M +1.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 -$292M -$71.9M -$13.5M -23.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$279M -$74.3M -$23.4M -46.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-09
Q1 2019 -$256M -$66.3M -$24.8M -59.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-09
Q4 2018 -$231M -$80M -$44.7M -127% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$186M -$58.4M -$27.3M -87.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$159M -$50.9M -$23.5M -85.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-07
Q1 2018 -$135M -$41.4M -$15.8M -61.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-07
Q4 2017 -$119M -$35.3M -$17.1M -93.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 -$102M -$31.1M -$5.72M -22.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$96.7M -$27.4M -$8.55M -45.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 -$88.1M -$25.7M -$9.09M -54.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$79M -$18.2M +$3.01M +14.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 -$82.1M -$25.4M -$13.5M -114% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$68.6M -$18.9M -$3.94M -26.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$64.6M -$16.6M -$7.4M -80.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 -$57.2M -$21.2M -$10.7M -102% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 -$46.5M -$11.9M -$5.95M -101% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 -$40.6M -$14.9M -$10.4M -231% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$30.1M -$9.16M -$2.11M -29.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 -$28M -$10.5M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-09
Q3 2014 -$5.92M -$3.38M -133% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$4.51M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$7.05M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q3 2013 -$2.54M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q4 2012 -$4.11M Aug 22, 2012 Dec 31, 2012 10-K 2015-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.